You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 2, FEBRUARY 1958 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Studies of the Bone Marrow in Immunological Granulocytopenia

Following Administration of Salicylazosulfapyridine

ROBERT S. EVANS, M.D.; WILLIAM P. FORD, Jr., B.S.

AMA Arch Intern Med. 1958;101(2):244-251.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Severe granulocytopenia associated with a decreased resistance to infections was recognized as a new disease syndrome in 1922.1 Nine years later Kracke directed attention to the causal relationship of drugs.2,3 Shortly thereafter, Madison and Squier4 collected evidence that, of all drugs then in use, aminopyrine was most clearly implicated. These authors were also the first to reproduce granulocytopenia by the administration of aminopyrine to patients who had recovered from previous episodes associated with the use of an aminopyrine barbiturate preparation. A dose of 0.3 gm. by mouth was followed within hours by fever, malaise, and a precipitous fall in granulocytes in one patient. The second exhibited only a sharp drop in granulocyte count following the medication. These clinical experiments were repeated and confirmed by others.5,6

Plum's 7 studies of the bone marrow during the administration of aminopyrine to three sensitive patients are of particular interest. He noted a decrease in . . . [Full Text PDF of this Article]


Author Affiliations

Seattle With the Technical Assistance of Mary Tibbetts, B.A., M.T.

From the Medical Service, Veterans' Administration Hospital, and the Department of Medicine, University of Washington School of Medicine.


Footnotes

Submitted for publication Sept. 30, 1957.

This study was supported by a grant-in-aid from the United States Public Health Service. Project No. A-548 C5.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1958 American Medical Association. All Rights Reserved.